Ticker LaunchRegulation A · Tier 2
XEME Biopharma Holdings Inc.
XEME Biopharma Holdings Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on May 7, 2019 for up to $20M at $0.2 per security. The SEC qualified the offering on Nov 5, 2019.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $20M
- Offer price
- $0.2
- Security type
- Equity (common or preferred stock)
- Filed
- May 7, 2019
- Qualified
- Nov 5, 2019
- Industry
- Pharmaceutical Preparations
- State
- CA
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) May 7, 2019
- All filings on EDGAR CIK 1775196
Other qualified Biotech & pharma Reg A offerings
- Verax Research Services, Inc.May 4, 2020 · $50M
- Mystic Holdings Inc./NVMar 20, 2020 · $50M
- CBD Life Sciences Inc.Mar 11, 2020 · $2M
- Quadrant Biosciences IncMar 9, 2020 · $15M
- Scopus BioPharma Inc.Feb 4, 2020 · $1M
- JUVA LIFE INC./CanadaAug 20, 2019 · $49.9M